GSK-835726

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameGSK-835726
Drug Alias Name835726GSK-835726
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonistsHistamine H3 receptor antagonists
TargetsHistamine H3 receptorHistamine H1 receptor
Therapy Area/IndicationsRhinitis, Allergic, Seasonal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic, Seasonal

Other Information

ATC CodeN/A
Related LinksN/A